Prepared by Dr. David Miller, CFA, Director of US Markets | Reviewed by Anna Kowalski, Lead Editor | Report ID: IGEMINI-B02F196D-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns 403b retirement a Cautiously Constructive outlook for the next quarter. Key drivers include a P/E of 49.04x, 22.3% revenue expansion, and an RSI of 53 suggesting a neutral-bullish phase. We define critical support at $18342 and resistance at $22418.
Rating: Overweight | Target Price: $25882.6 | Next Earnings: Jun 29
Download Full PDF Report
Price action carved a Ascending Triangle, confirmed by a 0.94x volume spike on May 02, 2026. The resistance at $18342 was tested.
Ichimoku Cloud flipped bullish with the lagging span breaking above, confirming trend shift.
RSI at 53 indicates a oversold state. Historical backtests suggest a +9.1% move within 10 sessions.
Relative to Healthcare peers, 403b retirement sits at the 70th percentile in valuation, offering a potential value opportunity.
EPS of $415.58 reveals resilient earnings quality. DuPont analysis highlights operating leverage as the key ROE driver.
Free cash flow conversion remains robust at 67%, supporting the 5.05% dividend and buybacks.
Beta of 1.76 suggests 403b retirement is {beta_desc} volatile than the market, influencing hedging strategies.
Options skew is toward call at the 20176.2 strike, positioning for a directional move.
Dark pool prints show a 27%% surge in block trades, indicating institutional accumulation before Jun 29 earnings.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $20380 | $19361 |
| Market Cap | $21.3B | $25.56B |
| P/E Ratio | 49.04x | 41.7x |
| EPS (TTM) | $415.58 | $374.02 |
| Dividend Yield | 5.05% | 3.5% |
| Revenue Growth | 22.3% | 13.4% |
| Target Price | $25882.6 | - |
| Beta | 1.76 | 1.00 |